How We Work
A disciplined path from mission need to investment decision
Our process begins with operational relevance and develops into an investment assessment.
Each stage answers a different question and determines whether an opportunity should progress.
Mission Criticality is our first filter.
- Who needs this capability?
- What happens if it fails?
- Can something else replace it in time?
An opportunity must demonstrate a credible pathway to mission criticality before it advances to Investment Translation.
01
Capability Translation
Can the technology meet the mission need?
We develop and test a capability hypothesis: a clear explanation of how the proposed technology could deliver the required operational effect.
Our assessment covers four areas:
- Mission
- The user, required effect, consequences of failure and time constraints.
- Evidence
- Available technical results, their relevance to mission requirements and the next test needed.
- Environment & Interfaces
- Operating conditions, integration dependencies and compatibility with surrounding systems.
- Fieldability
- The requirements for qualification, deployment, support and sustainment.
The outcome may be an opportunity that is in scope, one that remains on watch while evidence develops, or one that is currently out of scope.
Passing this stage establishes a credible basis for further assessment. Qualification and deployment may still require substantial work.
02
Investment Translation
Can the company turn that capability into a viable business and a compelling investment?
- Product
- technical differentiation, robustness and defensibility as threats and competing solutions evolve.
- Team
- the ability to qualify, industrialise, integrate and scale in demanding markets.
- Adoption
- identifiable users, purchasing routes, barriers to deployment and a credible path to revenue.
- Capital fit
- funding needs, execution milestones and ownership economics consistent with the investment risk.
Operational evidence informs the investment case throughout this assessment.
03
Portfolio Construction
How should the investment fit within the fund?
We consider investment size, sequencing and capital reserved for future rounds alongside the opportunity’s stage, risks and contribution to the wider portfolio.
Follow-on investment is intended to depend on demonstrated progress against execution milestones.
Our core focus is on Seed and Series A opportunities, with selective Series B participation.
After investment: qualification, industrialisation and deployment
Our intended role is to work with founders on the obstacles that determine whether a capability reaches its users.
Support may include qualification planning, introductions to relevant end users and integrators, industrial partnerships, procurement pathways and preparation for subsequent financing.
Engagement with external organisations depends on their own priorities and decisions.
We also assess potential strategic acquisition pathways before investment and revisit them as the company develops.
A defined investment perimeter
Mission relevance and commercial potential must also fit our ethical framework.
Velaris excludes lethal offensive weapon systems, fully autonomous lethal weapons, and biological or chemical weapons.
Opportunities must also meet the applicable legal, sanctions and export-control requirements. These criteria apply throughout selection and portfolio monitoring.
Introduce your company
Tell us which user and mission your technology serves, what evidence you have today and what you need to achieve next.